Advanced search
Publication Cover
Amyloid
The Journal of Protein Folding Disorders
Volume 23, 2016 - Issue 1
Submit an article Journal homepage
486
Views
19
CrossRef citations to date
0
Altmetric
Original Article

Long-term outcome of patients with hereditary transthyretin V30M amyloidosis with polyneuropathy after liver transplantation

Kosuke OkumuraDepartment of Neurology,
,
Taro YamashitaDepartment of Neurology, ;Amyloidosis Diagnostic Unit, Correspondence[email protected]
,
Teruaki MasudaDepartment of Neurology,
,
Yohei MisumiDepartment of Neurology,
,
Akihiko UedaDepartment of Neurology,
,
Mitsuharu UedaDepartment of Neurology,
,
Konen ObayashiDepartment of Morphological and Physiological Sciences,
,
Hirofumi JonoDepartment of Clinical Pharmaceutical Sciences, and
,
Satoshi YamashitaDepartment of Neurology,
,
Yukihiro InomataDepartment of Pediatric Surgery and Transplantation, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan
&
Yukio AndoDepartment of Neurology,
show all
Pages 39-45 | Received 28 Jul 2015, Accepted 18 Nov 2015, Published online: 13 Jan 2016

Citations (19)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Taro Yamashita, Mitsuharu Ueda, Masayoshi Tasaki, Teruaki Masuda, Yohei Misumi, Kotaro Takamatsu, Konen Obayashi & Yukio Ando. (2017) Establishment of a diagnostic center for amyloidosis in Japan by Kumamoto University. Amyloid 24:sup1, pages 169-170.
Read now
Taro Yamashita, Mitsuharu Ueda, Nobuyuki Saga, Kiyonori Nanto, Masayoshi Tasaki, Teruaki Masuda, Yohei Misumi, Seitaro Oda, Akiko Fujimoto, Tomoko Amano, Kotaro Takamatsu, Satoshi Yamashita, Konen Obayashi, Hirotaka Matsui & Yukio Ando. (2016) Hereditary amyloidosis with cardiomyopathy caused by the novel variant transthyretin A36D. Amyloid 23:3, pages 207-208.
Read now

Articles from other publishers (17)

Carlos Casasnovas, Laura Lladó, Cristina Borrachero, Patricia Valentina Pérez-Santamaría, Francisco Muñoz-Beamud, Inés Asunción Losada-López, Maria Carme Baliellas-Comellas & Juan González-Moreno. (2023) A narrative review and expert recommendations on the assessment of the clinical manifestations, follow-up, and management of post-OLT patients with ATTRv amyloidosis. Therapeutic Advances in Neurological Disorders 16.
Crossref
Francisca Pinheiro, Irantzu Pallarès, Francesca Peccati, Adrià Sánchez-Morales, Nathalia Varejão, Filipa Bezerra, David Ortega-Alarcon, Danilo Gonzalez, Marcelo Osorio, Susanna Navarro, Adrián Velázquez-Campoy, Maria Rosário Almeida, David Reverter, Félix Busqué, Ramon Alibés, Mariona Sodupe & Salvador Ventura. (2022) Development of a Highly Potent Transthyretin Amyloidogenesis Inhibitor: Design, Synthesis, and Evaluation. Journal of Medicinal Chemistry 65:21, pages 14673-14691.
Crossref
Sadao Hikishima, Kenji Sakai, Akio Akagi, Hiroki Yamaguchi, Shutaro Shibata, Koji Hayashi, Hiroto Nakano, Mizuki Kanemoto, Yuta Usui, Yu Taniguchi, Junji Komatsu, Keiko Nakamura-Shindo, Ichiro Nozaki, Tsuyoshi Hamaguchi, Kenjiro Ono, Kazuo Iwasa & Masahito Yamada. (2022) Deterioration after Liver Transplantation and Transthyretin Stabilizer Administration in a Patient with ATTRv Amyloidosis with a Leu58Arg (p.Leu78Arg) <i>TTR</i> Variant. Internal Medicine 61:15, pages 2347-2351.
Crossref
Nobutaka Nagano, Atsuko Muranaka, Ryo Nishikawa, Wataru Ohwada, Hidemichi Kouzu, Naoyuki Kamiyama, Takefumi Fujito, Atsushi Mochizuki, Daigo Nagahara, Mitsuhiro Nakanishi, Yukiko Ohkubo, Shin Hisahara, Satoshi Nakao, Nagaaki Katoh, Aki Ishikawa, Akihiro Sakurai & Toshiyuki Yano. (2022) Early Detection of Cardiac Amyloidosis in Transthyretin Mutation Carriers. International Heart Journal 63:1, pages 168-175.
Crossref
Shinya Oginezawa, Tomohiko Ishihara, Yohei Iwafuchi, Yuya Hatano, Ken Kashimura & Osamu Onodera. (2022) ATTRv amyloidosis with early improvement demonstrated by the 6-minute walk test following Patisiran therapy: a case reportパチシランにより早期から6分間歩行試験で改善を認めたATTRvアミロイドーシスの1例. Rinsho Shinkeigaku 62:5, pages 375-379.
Crossref
Monica Alcantara, Michelle M. Mezei, Steven K. Baker, Ari Breiner, Priya Dhawan, Amanda Fiander, Nowell M. Fine, Christopher Hahn, Hans D. Katzberg, Shahin Khayambashi, Rami Massie, Genevieve Matte, Brendan Putko, Zaeem Siddiqi, Diego Delgado & Vera Bril. (2021) Canadian Guidelines for Hereditary Transthyretin Amyloidosis Polyneuropathy Management. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 49:1, pages 7-18.
Crossref
Sandrigo Mangini, Bianca de Cássia Sabbion, Robinson Poffo, Sérgio Paiva MeiraFilhoFilho, Márcio Dias de Almeida & Fernando Bacal. (2021) First Combined Heart-Liver Transplant in Amyloidosis Due to Transthyretin Mutation in Brazil: Impact of the Liver on Reducing anti-HLA Antibodies. ABC: Heart Failure & Cardiomyopathy 1:2, pages 167-170.
Crossref
Adriano-Valerio Schettini, Laura Llado, Julie K Heimbach, Jose Gonzalez Costello, Marie Tranäng, Olivier Van Caenegem, Richard C Daly, Peter Van den Bergh, Carlos Casasnovas, Joan Fabregat, John J Poterucha, Maxime Foguenne, Bo Göran Ericzon & Jan Lerut. (2021) Symptomatic Val122del mutated hereditary transthyretin amyloidosis: Need for early diagnosis and prioritization for heart and liver transplantation. Hepatobiliary & Pancreatic Diseases International 20:4, pages 323-329.
Crossref
Héctor Cristóbal Gutiérrez, Ana Lara Pelayo-Negro, David Gómez Gómez, Miguel Ángel Martín Vega & Marta Valero Domínguez. (2020) Overview of treatments used in transthyretin-related hereditary amyloidosis: a systematic review. European Journal of Hospital Pharmacy 27:4, pages 194-201.
Crossref
Alejandra González‐Duarte, Isabel Conceição, Leslie Amass, Marc F. Botteman, John A. Carter & Michelle Stewart. (2020) Impact of Non-Cardiac Clinicopathologic Characteristics on Survival in Transthyretin Amyloid Polyneuropathy. Neurology and Therapy 9:1, pages 135-149.
Crossref
Morie A. Gertz, Michelle L. Mauermann, Martha Grogan & Teresa Coelho. (2019) Advances in the treatment of hereditary transthyretin amyloidosis: A review. Brain and Behavior 9:9.
Crossref
Masamichi Inoue, Mitsuharu Ueda, Taishi Higashi, Takayuki Anno, Kazuya Fujisawa, Keiichi Motoyama, Mineyuki Mizuguchi, Yukio Ando, Hirofumi Jono & Hidetoshi Arima. (2019) Therapeutic Potential of Polyamidoamine Dendrimer for Amyloidogenic Transthyretin Amyloidosis. ACS Chemical Neuroscience 10:5, pages 2584-2590.
Crossref
Yoshiki Sekijima, Mitsuharu Ueda, Haruki Koike, Sonoko Misawa, Tomonori Ishii & Yukio Ando. (2018) Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm. Orphanet Journal of Rare Diseases 13:1.
Crossref
Xiangshun Li, Yanyi Lyu, Jingling Shen, Yanshuang Mu, Lixia Qiang, Li Liu, Kimi Araki, Bruno P. Imbimbo, Ken-ichi Yamamura, Shoude Jin & Zhenghua Li. (2018) Amyloid deposition in a mouse model humanized at the transthyretin and retinol-binding protein 4 loci. Laboratory Investigation 98:4, pages 512-524.
Crossref
Raghav Bansal, Umer Syed, Jacob Walfish, Joshua Aron & Aaron Walfish. (2018) Small Bowel Amyloidosis. Current Gastroenterology Reports 20:3.
Crossref
Taro Yamashita, Mitsuharu Ueda, Yohei Misumi, Teruaki Masuda, Toshiya Nomura, Masayoshi Tasaki, Kotaro Takamatsu, Keiko Sasada, Konen Obayashi, Hirotaka Matsui & Yukio Ando. (2017) Genetic and clinical characteristics of hereditary transthyretin amyloidosis in endemic and non-endemic areas: experience from a single-referral center in Japan. Journal of Neurology 265:1, pages 134-140.
Crossref
J. Finsterer, J. Wanschitz, S. Quasthoff, S. Iglseder, W. Löscher & W. Grisold. (2017) Causally treatable, hereditary neuropathies in Fabry's disease, transthyretin-related familial amyloidosis, and Pompe's disease. Acta Neurologica Scandinavica 136:6, pages 558-569.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.